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Technische Universita¨t Dresden, Dresden, GermanyABSTRACT Distinct lipid environments, including lipid rafts, are increasingly recognized as a crucial factor affecting
membrane protein function in plasma membranes. Unfortunately, an understanding of their role in membrane protein activation
and oligomerization has remained elusive due to the challenge of characterizing these often small and transient plasma
membrane heterogeneities in live cells. To address this difficulty, we present an experimental model membrane platform based
on polymer-supported lipid bilayers containing stable raft-mimicking domains (type I) and homogeneous cholesterol-lipid
mixtures (type II) into which transmembrane proteins are incorporated (avb3 and a5b1 integrins). These flexible lipid platforms
enable the use of confocal fluorescence spectroscopy, including the photon counting histogrammethod, in tandem with epifluor-
escence microscopy to quantitatively probe the effect of the binding of native ligands from the extracellular matrix ligands
(vitronectin and fibronectin for avb3 and a5b1, respectively) on domain-specific protein sequestration and on protein oligomeri-
zation state. We found that both avb3 and a5b1 sequester preferentially to nonraft domains in the absence of extracellular matrix
ligands, but upon ligand addition, avb3 sequesters strongly into raft-like domains and a5b1 loses preference for either raft-like or
nonraft-like domains. A corresponding photon counting histogram analysis showed that integrins exist predominantly in a mono-
meric state. No change was detected in oligomerization state upon ligand binding in either type I or type II bilayers, but
a moderate increase in oligomerization state was observed for increasing concentrations of cholesterol. The combined findings
suggest a mechanism in which changes in integrin sequestering are caused by ligand-induced changes in integrin conformation
and/or dynamics that affect integrin-lipid interactions without altering the integrin oligomerization state.INTRODUCTIONThe modern view of the plasma membrane is that it is a
highly complex fluid system comprised of rapidly changing
heterogeneous patches of lipids that may regulate the
location and functionality of membrane-associated proteins
(1,2). One such class of heterogeneous patches consists
of lipid rafts, which are defined as dynamic assemblies
enriched in cholesterol (CHOL), sphingolipids, and GPI-
anchored proteins (3). Rafts of membrane proteins, in con-
cert with other proteins or lipids, induce a variety of cellular
activities, including formation of signaling platforms (4),
pathogenesis through endocytosis (5), and changes in
cellular adhesion, cell morphology, and angiogenesis (6).
An important aspect of lipid rafts is that protein function-
ality can be regulated by a change in raft association or
sequestration (7).
Several possible mechanisms may induce a change in
sequestration of receptors. Sequestration of proteins into
lipid rafts may arise due to protein acylation (8), receptor
clustering (9), ligand addition (10), or other specific
protein-protein interactions (11). CHOL concentration isSubmitted June 10, 2011, and accepted for publication August 30, 2011.
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0006-3495/11/10/1642/9 $2.00known to be a critical factor in sequestration events, as
exemplified by CHOL depletion studies that showed a
change in protein activity level that was restored when
CHOL returned to normal levels (12,13). However, the
underlying mechanisms of protein sequestering, and the
interplay among them, are still not well understood because
it can be very challenging to distinguish contributions from
different factors in plasma membranes. CHOL depletion, for
example, may induce artifacts such as cytoskeletal destabi-
lization (14). Furthermore, the common practice of identi-
fying proteins found in detergent-resistant membranes
with rafts appears to be, in part, prone to inaccurate analyses
(15). Rafts are small in size, and protein-lipid raft associa-
tions are dynamic and often short-lived (16,17). One method
for increasing raft size and duration in live cells is cross-
linking, i.e., through cross-linking antibodies, GM1-cholera
toxin B (CTxB) cross-linking, or mechanical cross-linking
of ligands (18–21). These methods, however, artificially
induce cell responses. Lingwood and Simons (22) called
this problem, akin to Heisenberg’s uncertainty principle,
the observer effect of lipid raft studies: before heterogeneity
can be observed in plasma membranes, it must first
be induced. Consequently, model studies containing raft-
mimicking lipid mixtures have also been pursued. In silico
progress has been slow, in part due to the limited availability
of complete crystal structures for transmembrane proteins.
Synthetic bilayers provide a promising avenue of investiga-
tion. If lipid bilayers are composed of ternary mixtures ofdoi: 10.1016/j.bpj.2011.08.040
Integrin Sequestering 1643CHOL, saturated lipids, and unsaturated lipids, they can
phase-separate into regions of higher order with more
CHOL (lo) and lower order with less CHOL (ld) (23,24).
Sequestration of membrane receptors and response of
sequestration to cross-linking antibodies have also been
confirmed in model membrane environments (25–27).
The elegance of model systems lies in the fact that they
enable one to study the sequestering and oligomerization
behaviors of receptors in response to biological stimuli
without the use of artificial cross-linking agents. Applying
this concept, we expanded the model membrane approach
to study the effects of ligand addition to the integrins
avb3 and a5b1 incorporated into ternary phase-separating
planar polymer-tethered model lipid bilayers. The poly-
mer-tethered planar system enables stable lipid phase
separations (28,29), incorporation of biologically active
transmembrane proteins (30–32), and sensitive fluorescence
fluctuation spectroscopy investigations into lipid phase par-
titioning and protein oligomerization state (33). Integrins
are well suited for these experiments because they are impli-
cated in many raft-associated activities, including cell adhe-
sion, morphology, motility, and angiogenesis. They also act
as bidirectional signaling platforms in which functionality is
regulated by different factors, including binding of ligands
or other membrane proteins, activation through divalent
cations, signals from the cytosolic environment, and micro-
clustering (6). Using confocal spectroscopy XY scans, we
show that avb3 and a5b1 in a polymer-tethered lipid bilayer
in PBS buffer partition preferentially to ld domains, and
ligand addition alone causes substantial, quantifiable shifts
in protein partitioning to lo domains. Despite these substan-
tial shifts, ligand addition had essentially no impact on
receptor oligomerization state, as determined by photon
counting histograms (PCHs) for receptors incorporated
into binary lipid/CHOL bilayers or ternary raft-mimicking
bilayers. By contrast, independently of ligand addition, the
concentration of CHOL in binary bilayers affected receptor
oligomerization to a moderate degree.MATERIALS AND METHODS
Materials
The lipopolymer 1,2-dioctadecyl-sn-glycero-3-N-poly(2-methyl-2-oxazo-
line)50 (diC18M50) was synthesized according to previously described
procedures (34). Lipopolymer-coated quantum dots were synthesized
according to established procedures (35). The phospholipids 1-stearoyl-2-
oleoyl-sn-glycero-3-phosphocholine (SOPC), 1,2-dioleoyl-sn-glycro-3-phos-
phocholine (DOPC), 1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC),
1,2-dipalmitoyl-sn-glycero-3-phosphothioethanol (DPTE), 1,2-dioleoyl-sn-
glycro-3-phosphoethanolamine (DOPE), CHOL,) and ganglioside GM1
(ovine brain) were purchased from Avanti Polar Lipids (Alabaster, AL). The
fluorescently labeled phospholipids N-(7-nitrobenz-2-oxa-1,3-diazol-4-
yl)-1,2-dihexadec-anoyl-sn-glycero-3-phosphoethanolamine, triethylammo-
nium salt (NBD-DHPE), N-(6-tetramethylrhodamine-thiocarbamoyl)-1,
2-dihexadecanoyl-sn-glycero-3-phosphoethanolamine, triethylammonium
salt (TRITC-DHPE), Alexa-555 labeled CTxB (CTxB-555), and kits for flu-
orescently labeling antibodieswith TRITCorAlexa-555were obtained fromInvitrogen (Carlsbad, CA). Chloroform (HPLC grade; Fisher Scientific,
Pittsburgh, PA) was used as a spreading solvent for lipid monolayers at the
air-water interface, and Milli-Q water (pH ¼ 5.5, 18 MU-cm resistivity;
Millipore, Billerica, MA) was used as a subphase material for all experi-
ments. Glass coverslips were pretreated by baking for 3 h at 515C, followed
by sonication in a bath sonicator for 45min first in 1%SDS, thenNaOH satu-
ratedMeOH, and finally 0.1%HCl (Fisher Scientific), with extensive rinsing
between sonication steps and after the final sonication step, and stored in
Milli-Q for no more than 1 week. The proteins human integrin avb3 and
a5b1, octyl-b-D-glucopyranoside (OG) formulation; monoclonal antibodies
(MAbs) anti-integrin avb3, clone LM609, and anti-integrin a5b1, clone
JBS5; vitronectin, human purified (VN); and fibronectin, human purified
(FN) were purchased from Millipore (Billerica, MA). Rhodamine 6G was
purchased from Sigma-Aldrich (St. Louis, MO). Antibodies were labeled
as described in the antibody labeling kits. Efficacy of labeling was checked
by determining brightness by fluorescence correlation spectroscopy (FCS).Construction of polymer-tethered phospholipid
bilayers
Polymer-tethered phospholipid bilayers were built with the use of succes-
sive Langmuir-Blodgett (LB) and Langmuir-Schaefer (LS) film transfers
according to standard procedures (28). To form the first (LB) monolayer,
a chloroform solution of a mixture of diC18M50 and lipids was spread at
the air-water interface of a film balance with dipper (Labcon, Darlington,
UK). The composition was 5 mol % diC18M50, 31.5 mol % DPPC and
CHOL, and 32% DOPC for type I bilayers. For type II bilayers, the compo-
sition consisted of 5 mol % diC18M50 and 0, 5, or 30 mol % CHOL, with the
balance consisting of SOPC. The monolayer was compressed and, after
stabilization (30 min for type I bilayers, 20 min for other mixtures), trans-
ferred to a glass substrate (28). Next, a chloroform solution containing
a lipid mixture (the LS mixture) was spread at the air-water interface and
compressed. For type I bilayers, the LS mixture consisted of 1:1:1 DPPC/
CHOL/DOPC. For type II bilayers, the LS mixture consisted of 0, 5, or
30 mol % CHOL, with the balance consisting of SOPC. LS transfer was
accomplished by stabilizing the LS monolayer with a depression slide posi-
tioned underneath the air-water interface, and then carefully pushing the
glass substrate containing the LB layer onto the underlying depression
slide. With the use of a transfer dish, the depression slide was removed
and the bilayer was transferred into a petri dish, where the Milli-Q was re-
placed by PBS (Fisher Scientific, 10 concentration, diluted in Milli-Q).
Incorporation of proteins into bilayers
Proteins were reconstituted into model bilayers by means of a modified
Rigaud technique (36), also known as the direct protein incorporation
method (37). All protein studies were carried out in PBS buffer at room tem-
perature. Membrane proteins stabilized in 100 mM OG (1.3  1011 mol
proteins leading to bilayer concentrations of at most 103 mol %) were
added to the PBS solution above the bilayer (6 mL of PBS) for 1.5–2 h,
followed by removal of surfactant using a single layer of SM-2 biobeads
previously slurried in PBS (Bio-Rad, Hercules, CA) applied for 15 min to
solution over bilayers. Incorporation of proteins into type I bilayers was
assisted by initially diluting the proteins into 1 mL of 250 mM OG before
addition to the PBS solution above the bilayer, leading to a detergent concen-
tration in the presence of the bilayer of ~0.002 cmc, but this step was not
necessary for type II bilayers. Presoftening of the bilayer by addition
of OG or other detergent before protein incorporation (37–39) was not
required at these low protein concentrations (250 pM) and long incubation
times. Extensive rinsing in PBS ensured efficient removal of surfactant, as
confirmed by analysis of domain shapes (see Fig. S1 in the SupportingMate-
rial) and lipid fluidity as discussed below. Fluorescently labeled MAbs were
then added for 2–4 h and excess antibodies were removed by rinsing. Anti-
body binding assays were used to confirm the functional reconstitution of
integrins, and fluidity was also checked. After data were acquired on theseBiophysical Journal 101(7) 1642–1650
1644 Siegel et al.systems, FN or VN was added in a 1:1 ratio to membrane proteins and
permitted to equilibrate 3–4 h, and data were taken on the same substrates.
Several experiments were conducted at 12 h after ligand addition, and no
differences were observed. Unbound FN and VN were removed by rinsing
before imaging. MAbs were added to bilayers in the absence of integrins
as a control to check for nonspecific binding of antibodies.Microscopy techniques
A commercial ConfoCor 2 (Zeiss, Jena, Germany) was used for epifluores-
cence (EPI) microscopy and fluorescence fluctuation spectroscopy (FFS).
EPI was conducted with the use of an inverted optical microscope (Axiovert
200M, Zeiss, Oberkochen, Germany) in which the beam was focused to the
sample by a microscopy objective (C-Apochromat, water immersion, 40
NA¼ 1.2; Zeiss). EPI studies were undertaken with a Zeiss AxioCamMRm
monochrome digital camera and Axiovision 4.8 software or a CoolSNAPfx
camera (Roper Scientific, Princeton, NJ) and Roper Scientific imaging soft-
ware. FFS data were acquired using a 1.8 mW HeNe laser (543 nm) with a
560–605 nm emission filter (red channel) or a 30 mWArgon laser (514 nm)
with a 500–530 emission filter (green channel). We performed confocal
spectroscopic XY (CS-XY) scans (10 10 mm, 0.5 mm steps) of both chan-
nels after taking EPI micrographs of the same location. Control CS-XY
scans were taken of bilayers with NBD-PE and no proteins to determine
the amount of bleed-through from the green channel to the red channel.
FFS data for FCS and PCH analyses were acquired for 50 s runs on the
bilayer or in solution, using the same pinhole size, with focusing of planar
systems accomplished by maximizing peak count rates from single fluo-
rescent molecules diffusing through the confocal volume. Ternary lipid
mixtures (type I) induced phase separations into lo (liquid-ordered) and ld
(liquid-disordered) domains, which were visualized by EPI through one
of three NBD-PE labeling strategies: 1), addition of 0.5 mol % NBD-PE
directly to the bilayer with a correction for background bleed-through in
the CS-XY scans; 2), addition of 0.2 mol % NBD-PE (sufficiently low to
avoid the need for background correction); or 3), addition of NBD-PE
only after completion of all protein data through the use of fusogenic vesicles
(35). All three strategies provided similarly accurate quantitative analyses
of protein distributions. We investigated protein diffusion using wide-field,
single-molecule fluorescence microscopy of membrane proteins in dilute
(108) concentrations after fluorescent MAb labeling on an inverted micro-
scope (Zeiss Axiovert S100TV) as previously described (40). Further details
about this methodology are provided in the Supporting Material. We
investigated lipid diffusion for the purpose of analyzing bilayer fluidity by
incorporating 2 103 mol%TRITC-DHPE into type I and type II bilayers,
and using FCS to determine characteristic diffusion times for the lipids
before and after addition of detergent and rinsing with biobeads.Data analysis
We analyzed integrin sequestering by identifying partition coefficients
(Kp (lo/ld)), defined as Ilo/Ild (41) from CS-XY scans. Raw scans were cor-
rected for NBD and background contributions to determine protein signal
average intensities in lo phase (Ilo) and ld phase (Ild). To quantify changes
in Kp, we introduce Eraft, defined as the difference in signal intensities
between lo and ld phases normalized by the sum of the signal intensities.
Eraft ¼ ðIlo  IldÞðIlo þ IldÞ: (1)
For example, for a system perturbed by the addition of ligands, thechange in raftophilic excess, divided by two, equals the fraction of proteins






: (2)Biophysical Journal 101(7) 1642–1650We monitored integrin oligomerization behavior using PCHs of ava-
lanche photodiode photon counts (42,43). To ensure that the data were suffi-
ciently robust above background for the low-concentration diffusing
proteins on the bilayer, we also analyzed the intensity trace. We found
that when the average signal for the top 1% of the counts collected by inten-
sity trace were at least 20-fold above the average count rate, sufficient data
were available to fit the PCH data to a PCH algorithm-generated curve.
After finding the average number and brightness of the fluorescent particles
(Navg, ε), as described more fully in the Supporting Material, we refitted the
data to look for dimers by assuming a second fluorescent species of twice the
brightness and finding the average number for both the primary species and
secondary species (Navg, ε, Navgdimer , εdimer (¼ 2ε)). Navg and Navgdimer were
then used to determine Xdimer (mole fraction dimers). We tested the PCH
model using fluorescent particles known to be monomers, such as Rhoda-
mine 6G, MAbs in solution, and TRITC-DHPE in a bilayer, and found that
these species had Xdimer < 1% (data not shown). The data were also refit
with a model encompassing tetramers, which showed correspondingly
similar results for both the control systems and the membrane proteins of
interest (data not shown). It was also necessary to calibrate the PCH algo-
rithm for brightness of particles in solution relative to particles in a thin
slab, such as a planar bilayer (44). This was done by constructing a bilayer
with SOPC and 2 102mol%DPTE and addingmaleimide functionalized
quantum dots (35). We compared the PCH calculations for brightness of the
QDs on the bilayer with the brightness of dilute QDs in solution, and deter-
mined that the brightness of the species in solution and the brightness of the
species on the bilayer were within 5% of each other (Fig. S2).RESULTS AND DISCUSSION
Determination of fluidity of avb3 and a5b1
incorporated into model bilayers
Type I and type II lipid bilayers with 5 mol % DiC18M50 in
the LB layer were constructed, and integrins were incorpo-
rated therein and subsequently labeled with MAbs as
described above. We checked the integrity of the bilayers
before protein addition and after detergent extraction by
EPI analysis of the bilayers and by determining characteristic
diffusion times for lipid probes usingFCS.These experiments
showed no change in bilayer domain structure (Fig. S1) or
lipid fluidity for both type I and type II (0% CHOL) bilayers
within the experimental uncertainty of 5% (data not shown).
The EPI analysis showed no statistically significant aggrega-
tion of integrins on the bilayer. To quantify the functional
reconstitution and lateral fluidity of integrins in planar
membrane systems, we determined the lateral diffusion of
avb3 and a5b1 reconstituted into type II (0% CHOL) bilayers
before (VN/FN) and after (þVN/FN) ligand binding.
The calculated diffusion coefficients were as follows: for
avb3, D ¼ 0.39 5 0.04 (VN), 0.42 5 0.04 (þVN); for
a5b1 D ¼ 0.71 5 0.07 (FN), 0.87 5 0.08 (þFN; all
values mm2s1), immobile fraction (IF)< 10% by inspection
of cumulative distribution functions). These diffusion data
are in good agreement with data for aIIbb3 integrins reconsti-
tuted onto other planar model membranes, but differ in terms
of IF (45,46). The differences in IF can be attributed to
the different protein labeling and reconstitution strategies
used. (In the aIIbb3 system, integrins are fluorescently labeled
using 5-(and-6)-carboxy-tetra-methylrhodamine succini-
midyl ester and then are reconstituted via proteosomes, in
Integrin Sequestering 1645which both membrane protein orientations in the planar
membrane system are likely to occur with similar probabili-
ties. In this case, a substantial IF can be expected because
integrins pointing with their ectodomains toward the solid
substrate are immobile. The DPI reconstitution method, as
used in the current study, has been shown to lead to a more
unidirectional incorporation of transmembrane proteins
(37). By monitoring proteins through the use of fluorescent
antibodies that only bind to the protein’s extracellular
domain, this work also assured that only the properties of
correctly oriented proteins (extracellular domain points to
water phase) are analyzed, which are less prone to immobili-
zation in the planar bilayer.)Determination of raft sequestration of proteins
before and after ligand binding
To test the sensitivity of the experimental EPI/FFS setup, we
constructed type I bilayers with registered lo and ld domains
with an addition to the LS mixture of 2  103 mol % GM1
and 0.5 mol % of the lipid raft marker NBD-PE. CTxB-555
was subsequently added and CS-XY scans were performed.
As expected, the raftophilic CTxB colocalized with the
NBD-PE: Eraft for CTxB ¼ 0.685 0.07. This corresponds
to a Kp of 5.2 5 1.2, verifying the sensitivity of the type I
bilayers to induce sequestration in the GM1/CTxB system.
Next, type I bilayers with registered lo and ld domains
were constructed with 0.5 mol % NBD-PE added to the
LS mixture, and avb3 was incorporated as described above.
After EPI micrographs were taken (Fig. 1, C and F), CS-XY
scans were performed, representatives of which are shown
in Fig. 1, where the same area is scanned by the red (protein)
channel (A and D) and the green (NBD) channel (B and E).
A comparison of the CS-XY scans shows that before addi-
tion of VN, avb3 displays a marked preference for the non-
raft ld phase (Fig. 1, A and B). As illustrated in Fig. 1, D–F,
adding VN to the same substrate induced a dramatic change
in raft preference. The avb3 proteins switched from an ldFIGURE 1 (A) CS-XY scan of avb3  VN. (B) CS-XY scan of NBD-PE
in the same location as A. (C) EPI micrograph of NBD-PE, same location as
A. (D) CS-XY scan of avb3þVN. (E) CS-XY scan of NBD-PE, same loca-
tion as D. (F) EPI micrograph of NBD-PE, same location as D. (A–F)
Box ¼ 10  10 mm2.preference to an lo preference (Fig. 1 D). The NBD-PE
distribution was not perturbed by the addition of VN
(Fig. 1 F). Motivated by the question of whether this large
change in raftophilicity was specific to the avb3 integrins
or was more generally applicable to other integrins, we per-
formed the experiment again, this time using a5b1 integrins
and FN as the ECM ligand; the results are shown in Fig. 2. In
similarity to the avb3 integrins, before addition of ligand,
the a5b1 partitioned preferentially to the ld phase (Fig. 2
A). Subsequent to FN addition, however, the a5b1 switched
to displaying no strong preference for either the ld or the lo
phase (Fig. 2 D). The results from the CS-XY scans are
quantified and tabulated, along with the partitioning
behavior of the GM1-CTxB system, in Fig. 3, which shows
Eraft for avb3 and a5b1 before and after ligand binding (VN
and FN, respectively), and Eraft for CTxB-555 linked to
GM1. The fraction of receptors that translocated from the
ld domains to lo domains can be quantified as Xmigrate, as dis-
cussed above (Eq. 2). The CS-XY scans showed Xmigrate ¼
53 5 6% for avb3 integrins, and Xmigrate ¼ 27 5 3% for
a5b1 integrins.
Cell studies have shown that inactive and unbound integ-
rins, similarly to the proteins reconstituted into the model
bilayers in PBS buffer in our experiment, are nonraft-asso-
ciated (19,48). By contrast, integrin signaling and involve-
ment in cell adhesion, motility, and angiogenesis are all
raft-related activities, as demonstrated by studies involving
alteration of plasma membrane CHOL levels or association
with other raft-associated proteins (49–52). It appears that in
the model system presented here, binding to ECM ligands
alone suffices to increase a preference in avb3 and a5b1
for the CHOL-rich (lo) phase, even in the absence of other
protein cofactors, activating cations, or known cross-linking
agents such as CTxB or cross-linking MAbs. It is notable
that avb3 is more sensitive to raft sequestration than a5b1.
This finding is intriguing in light of the observation that
avb3 regulates the adhesive and phagocytic activity of
a5b1 (53). Several research groups have investigated theFIGURE 2 (A) CS-XY scan of a5b1  FN. (B) CS-XY scan of NBD-PE
same location as A. (C) EPI micrograph of NBD-PE in the same location as
A. (D) CS-XY scan of a5b1þ FN. (E) CS-XY scan of NBD-PE, same loca-
tion as D. (F) EPI micrograph of NBD-PE, same location as D. (A–F)
Box ¼ 10  10 mm2.
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FIGURE 4 Fraction of dimers found through PCH analysis for avb3 (A)
and a b (B) before (light bars) and after (dark bars) ligand binding in type
FIGURE 3 Normalized difference in intensity between lo phase and ld
phase (Eraft) shown for GM1-CTxB and avb3 and a5b1 before and after
ligand addition (light bars:  ECM ligand; dark bars: þ ECM ligand).
Negative values of Eraft correspond to Kp < 1.
1646 Siegel et al.partitioning of raft-associated proteins using giant unilamel-
lar vesicles and giant plasma membrane vesicles. Results
show that the relative preference for ordered phases is
higher for these proteins than for nonraft-associated pro-
teins, and this preference increases upon addition of cross-
linking agents (25–27,54). Our system differs from those
approaches in that it is planar and investigates the oligomer-
ization state along with sequestration in the absence of arti-
ficial cross-linking.5 1
II bilayers. These data show that increasing CHOL increases oligomeriza-
tion for both avb3 and a5b1, but only to moderate levels, and ligand binding
has no statistically measurable effect on dimerization.
Determination of degree of oligomerization
Our previous data showed that ligand addition causes
substantial changes in Eraft, which raises the possibility
that these changes are accompanied by similar substantial
changes in integrin oligomerization state. Ligands are
known to induce clustering in membrane proteins other
than integrins (55–57). Moreover, clustering (through
agents such as GM1 or a cross-linking antibody) is known
to induce raftophilicity in integrins (20,58,59). To investi-
gate whether ligand addition by itself induces a change in
oligomerization state separately from any change that might
be induced by a change in lipid phase, we constructed
a series of type II bilayers, which do not phase-separate,
with 0, 5, and 30 mol % CHOL. We probed the oligomeri-
zation state of avb3 and a5b1 by analyzing the PCH data
acquired in these six systems before and after ligand
binding. The PCH curves and best fits for species brightness
are provided in Fig. S3 and Fig. S4. They show that the
integrins were primarily monomers both before and after
ligand binding, and the best fits for brightness for these
systems in each case were within 15% of the best fit for
the brightness of the MAbs in solution (Fig. S4). The results
for oligomerization state as deduced from solutions to the
PCH algorithm are shown in Fig. 4. For the avb3 system,
Xdimer is below 5% for the CHOL free bilayer, but increases
to 5–10% for 5 mol % CHOL and then to ~12% for the
30 mol % CHOL bilayer. The a5b1 system shows the
same trend, with possibly higher Xdimer (2–7%) found for
0% CHOL. This finding is interesting in light of the obser-Biophysical Journal 101(7) 1642–1650vation that reduction of CHOL levels leads to a reduction in
integrin functioning as observed by reduced cellular adhe-
sion capabilities (13). Of more importance, there is no statis-
tical difference in oligomerization state before (light bars)
and after (dark bars) ligand binding, with the possible
exception of a moderate increase in oligomerization after
ligand binding in the 5 mol % CHOL avb3 system.
After characterizing integrin oligomerization in type II
bilayers, we conducted corresponding experiments on raft-
mimicking type I bilayers, utilizing the dual EPI/FFS setup
to acquire FFS data in lo and ld phases for both avb3 and
a5b1 before and after ligand addition for the purpose of
analyzing oligomerization state in this system. The results
of these studies are shown in Fig. 5, which include the
PCH data sets as well as the findings for brightness relative
to MAbs in solution and Xdimer . PCH analysis shows that the
primary brightness of the integrins relative to the fluorescent
MAbs in solution was 77 5 9% before ligand binding and
815 9% after ligand binding, and thus was essentially the
same before and after ligand binding (Fig. 5 E). The rate of
dimerization was moderate, between 5 and 20 mol % for
both avb3 and a5b1 (Fig. 5 F), thus mirroring the results
found in the type II bilayers. Using our system and the
PCH algorithm, we were able to sensitively identify the
oligomerization state, and found that raft sequestration
due to monomeric, nonclustered ligands does not induce
oligomerization in either avb3 or a5b1 integrins.
FIGURE 5 (A–D) PCH curves for avb3 (A and
C) and a5b1 (B and D) before (light markers) and
after (dark markers) ligand binding in both lo phase
(A and B) and ld phase (C and D), along with PCH
curves for MAbs for integrins in solution (open
markers). MAbs data were acquired twice: at the
time of initial PCH acquisition (before ligand
binding) and at the time of subsequent PCH addi-
tion (after ligand binding). Dotted lines are best-
fit curves from the PCH algorithm. (E) Brightness
compared with MAbs in solution. (F) Fraction of
dimers found through PCH analysis of avb3 (left)
and a5b1 (right) before (light bars) and after
(dark bars) ligand binding in ld and lo phases.
Integrin Sequestering 1647Interestingly, our findings are in good agreement with an
early study involving octyl-glucoside, in which Hantgan
et al. (60) quantified the average molecular weight of the
integrin aIIbb3 through centrifugation before and after
addition of an RGD peptide ligand-mimetic. Their study
showed only a 10% increase in molecular weight after
ligand addition, and thus did not detect significant integrin
oligomerization upon ligand addition either. Our PCH data
are also supported by an elegant cell study that revealed
that ligand addition to avb3 or other forms of avb3 activation
was not capable of inducing clustering in the absence of
cytosolic-integrin linkages (58). These findings, as well as
our data, imply that avb3 integrin-ligand binding alone is
insufficient for integrin clustering or oligomerization. Inves-
tigators have studied a5b1 clustering by monitoring the
difference in strength of cellular adhesion (a proxy for integ-
rin clustering) of magnetic beads coated with different
concentrations of FN (21) or polymers linked with 1.7,
3.6, or 5.4 RGD peptides (20). In both cases, cellular adhe-
sion was significantly stronger (per ligand attached) for
clustered ligands than for monovalent ligands, indicating
that single ligands were not spontaneously forming clusters.
The combined integrin sequestering and PCH data clearly
indicate that ligand binding does not affect Xdimer for either
avb3 or a5b1 in phase-separating type I lipid mixtures. In
other words, the observed ligand-mediated changes of avb3
and a5b1 sequestering reported in Figs. 1–3 are not caused
by changes in receptor oligomerization state. Moreover,
our study demonstrates that the change in the fraction of pro-
teins that dimerize before and after ligand binding (%5%
difference in Xdimer on ligand addition) is far less than thefraction of proteins that migrated from disordered to ordered
lipid phases for both the a5b1 system, where 27% migrated
to induce an even distribution, and the avb3 system, where
54% migrated to the lo phase to induce a clear preference
for the lo phase. This platform therefore gives us the ability
to sensitively distinguish two separate aspects (i.e., raft-asso-
ciation and oligomerization state) and to conclude that
although ligand binding is sufficient to induce raft associa-
tion, it is not directly implicated in oligomerization.
Our data suggest that the observed protein sequestering is
due to ligand-induced conformational changes of integrins
influencing integrin-lipid interactions. It is well known
that ligand addition causes substantial structural changes
to both the ectodomains and transmembrane domains of
integrins. Electron microscopy studies have analyzed the
headgroup conformation of the EC domains of both avb3
and a5b1 in solution before and after quantitative exposure
to RGD peptides designed to mimic ECM ligands (61,62).
Both avb3 and a5b1 integrin fragments started in the resting,
bent conformations before they were exposed to ligands.
After ligand exposure, 98% of the avb3 headgroups adopted
an open conformation, even in the absence of the known
activating factor, Mn2þ (61), and 25% of the a5b1 protein
extracellular domains switched to the open conformation
(62). The position of the headgroups in relation to the mem-
brane also changes: integrins in the bent, resting position
have the RGD binding pocket near the plasma membrane,
but when activated, the RGD binding pocket is thought
to straighten out and pull far away from the membrane
(63). These changes in the ectodomain may influence the
observed change in sequestration directly by altering theBiophysical Journal 101(7) 1642–1650
1648 Siegel et al.ectodomain-membrane interface, or indirectly by inducing
changes in the integrin transmembrane domains. Further-
more, studies onmutations of integrins indicate that the trans-
membrane domains of the a and b subunits are associated
with substantial conformational changes in response to
external stimuli during processes associated with integrin
outside-in and inside-out signaling (64). Such conforma-
tional changes likely expose different residues and increase
the number of residues in the b subunit that reside within
the lipid membrane, thus changing the tilt angle of the
b subunit (65). This process may affect the mismatch
between the integrin transmembrane domain and the hydro-
phobic region of the lipid bilayer (66).CONCLUSION
This study demonstrates that polymer-tethered planar model
membranes are sensitive tools for studying transmembrane
proteins in different lipid environments and acquiring quan-
titative data regarding the partitioning preference and
oligomerization state of these systems. In this study, we
investigated integrin preferences for raft-like and nonraft-
like lipid environments using a bilayer phase-separated
into lo and ld phases. We found that two members of the
integrin family, avb3 and a5b1, partition preferentially into
the ld phase in their native state. However, addition of
ECM ligands induced a quantifiable change in the partition
preferences: FN caused a5b1 to lose preference and partition
equally between ordered and disordered states, and VN
caused avb3 to partition as strongly in the lo phase as it
did in the ld phase. In addition, using PCH, we were able
to quantify the degree of oligomerization of the proteins,
and found that most of the proteins, for both systems,
were monomers, and addition of ligands did not change
the oligomerization state. We further investigated the effect
of CHOL on the oligomerization state of the proteins, and
found for both systems that increasing CHOL levels
increased the oligomerization state, but only moderately,
and again, addition of ECM ligands had no effect on the
oligomerization state. Our data show that the experimental
platform presented here enables the isolation of different
factors that describe the effect of lipid rafts in regulating
membrane proteins without the use of confounding cross-
linking agents. This methodology can be expanded to study
the incorporation of other membrane proteins and cofactors
to the model system, as well as to study the effect of asym-
metric bilayers with lipid rafts contained in only the inner
or outer leaflet. Recent work showing that a5b1 appears to
recruit CHOL to the outer leaflet in plasma membranes
(67) makes this a fascinating avenue for investigation. The
methodology can further be combined with other approaches
involving the use of polymer-tethered lipid bilayers, such as
that used by Purrucker et al. (30) to investigate the cell adhe-
sion strength of integrins incorporated in polymer-tethered
model systems. Finally, we hope that this work will furtherBiophysical Journal 101(7) 1642–1650membrane proteinmolecular-dynamics simulations incorpo-
rating CHOL.SUPPORTING MATERIAL
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